Seagen
Utility Patent Applications
Last updated:
List of all Seagen patents 34 in total
| Status | Patent |
|---|---|
Application | Utility: DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY Filling date: 6 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: Glycan-Interacting Compounds and Methods of Use Filling date: 6 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: Masked Antibody Formulations Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS Filling date: 6 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGATE THERAPY Filling date: 6 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: CAMPTOTHECIN PEPTIDE CONJUGATES Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: METHODS OF TREATING BREAST CANCER WITH TUCATINIB Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-191P4D12 ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: CYSTEINE MUTATED ANTIBODIES FOR CONJUGATION Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: TREATMENT OF HER2 POSITIVE CANCERS Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: BETA-GLUCURONIDE-LINKER DRUG CONJUGATES Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: CD47 Antibodies and Uses Thereof for Treating Cancer Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER Filling date: 6 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: Methylene Carbamate Linkers for use with Targeted-Drug Conjugates Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: Glycan-Interacting Compounds and Methods of Use Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: ADCS WITH THIOL MULTIPLEX LINKERS Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERS Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF Filling date: 6 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES Filling date: 6 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: SELF-STABILIZING LINKER CONJUGATES Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: HYDROPHILIC ANTIBODY-DRUG CONJUGATES Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: Anti-TIGIT Antibodies Filling date: 6 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: Combination Therapy With LIV1-ADC and PD-1 Antagonist Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES Filling date: 6 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: CD123 Antibodies and Conjugates Thereof Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER Filling date: 6 Sep 2025 Issue date: 4 Feb 2021 |
Showing 1 to 34 of 34 patents.